News About: Goverment
Non NHI reimbursable drugs raised prices by almost 300%.
A civic group checked prices of about 970 drugs already transferred to a non-NHI reimbursement schedules effective from April 1 and found them already 300% hikes on average as compared to those before rescheduled.
...
National level comprehensive measures for toxic materials eyed
The Toxicity Research Institute of the KFDA has announced it will establish a series of comprehensive measures to systematically control all toxicity information via promotion of domestic toxicity evaluation infrastru...
Pharmaceutical industry to criticize the drug pricing policies of MOHW
Pharmaceutical industry sources says that the Ministry of Health and Welfare (MOHW) has implemented a series of unreal and ineffective drug pricing policies aiming to merely reduce the medical insurance prices, while ...
Drug bar code operation disclosed many weak points.
The drug bar code system raised many defects and problems in its field operation including the bar code reading, no bar coding, reading inability and other way of coding with sticker etc., which may give serious confu...
National TB care system in need of whole reshuffle.
The TBnet, a TB information surveillance system for TB patients, was found of no its full functions in catching TB patients because no physicians were cooperative to report them to the public health center as requeste...
MOHW mulls measures for medical market opening to overseas
From 2005 the medical service market was scheduled to open to the world, and now the MOHW took a step forward for the counter measures against such changes.
In the 1st meeting of "WTO/DDA Health and Welfare Commiss...
Exclusive bulk drugs to be waived from the registration list of bulk products
The Korea Food and Administration (KFDA) has announced it will formulate its guideline covering the registration of bulk products (e.g., designation of bulk drugs, requirements for necessary data and scope of waiver) ...
Prior consultation system of clinical trial drugs being popular
The prior consultation system for clinical trial drugs, which has been implemented from March 4 for an earlier establishment of protocol approval system, has attracted considerable attention from the pharmaceutical in...
Expansion of on-spot inspection eyed
The Health Insurance Review Agency (HIRV) has announced that a serious measures will be adopted to guarantee better medical quality and ensure the appropriateness of insurance related outlays in screening the drug rel...
Drug industry to decline data submission for drug costs.
The pharmaceutical industry declined, in an excuse of its business confidentiality, the cost data submission for manufactured and imported drugs requested by the MOHW.
The MOHW earlier called for the drug industry...
